As of Oct 26, 2026: Cytokinetics (CYTK) has a PDUFA date for Aficamten on Nov 14, 2026, in 19 days. Its Quality Score is -3. Scores as of 8:36 PM ET, 15 minutes behind.

CYTK FDA decision on Aficamten

Cytokinetics · PDUFA date

PDUFA dateNov 14in 19 days Quality Score-3Poor

Cash runway12quarters of cash

What the company said

PDUFA date for Aficamten: Nov 14, 2026.

PDUFA date, Nov 14, 2026. As Cytokinetics announced it.

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before CYTK's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How CYTK's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Nov 14, and the members' FDA calendar with filters and optional alerts.

More on CYTK and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.